Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1738]
News [4523]
Articles [207]
Editorials [9]
Conferences [164]
elearning [24]
Brain metastases developed from HER2 positive and triple negative breast cancer
Dr Patricia Steeg - National Cancer Institute, Bethesda, USA
Brain metastases developed from HER2 positive and triple negative breast cancer ( Dr Patricia Steeg - National Cancer Institute, Bethesda, USA )
14 Dec 2018
Role of chemotherapy in the treatment of metastatic breast cancer patients
Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani
Role of chemotherapy in the treatment of metastatic breast cancer patients ( Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani )
10 Dec 2018
Patient treatment preferences in relapsed/refractory multiple myeloma
Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos
Patient treatment preferences in relapsed/refractory multiple myeloma ( Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos )
3 Dec 2018
ECHELON-2: a large peripheral T-cell lymphoma trial
Dr Owen O'Connor - Columbia University Medical Centre, New York, USA
ECHELON-2: a large peripheral T-cell lymphoma trial ( Dr Owen O'Connor - Columbia University Medical Centre, New York, USA )
2 Dec 2018
Four cycles of chemotherapy as effective as six for diffuse large B-Cell...
Dr Viola Pöschel - Saarland University Medical School, Homburg, Germany
Four cycles of chemotherapy as effective as six for diffuse large B-Cell lymphoma ( Dr Viola Pöschel - Saarland University Medical School, Homburg, Germany )
1 Dec 2018
Luspatercept reduces need for blood transfusions in beta thalassemia and MDS
Dr Maria Domenica Cappellini - University of Milan, Milan, Italy
Luspatercept reduces need for blood transfusions in beta thalassemia and MDS ( Dr Maria Domenica Cappellini - University of Milan, Milan, Italy )
1 Dec 2018
Healthcare Technology Assessments
Prof Andrea Manca - University of York, UK, HARMONY Partner
Healthcare Technology Assessments ( Prof Andrea Manca - University of York, UK, HARMONY Partner )
26 Nov 2018
Risks and benefits of the HARMONY approach
Prof Andrea Manca - University of York, UK, HARMONY Partner
Risks and benefits of the HARMONY approach ( Prof Andrea Manca - University of York, UK, HARMONY Partner )
26 Nov 2018
The quality of the HARMONY Data Platform
Prof Andrea Manca - University of York, UK, HARMONY PartnerAna Heredia...
The quality of the HARMONY Data Platform ( Prof Andrea Manca - University of York, UK, HARMONY PartnerAna Heredia Casanoves - GMV, Spain, HARMONY Partner )
26 Nov 2018
Latest advances in acute lymphoblastic leukaemia and paediatrics in HARMONY
Prof Anthony Moorman - Newcastle University, UK, HARMONY Partner
Latest advances in acute lymphoblastic leukaemia and paediatrics in HARMONY ( Prof Anthony Moorman - Newcastle University, UK, HARMONY Partner )
26 Nov 2018
Paediatrics and AML at HARMONY
Prof Dirk Reinhardt - GPOH, Germany, HARMONY Partner
Paediatrics and AML at HARMONY ( Prof Dirk Reinhardt - GPOH, Germany, HARMONY Partner )
26 Nov 2018
Overcoming barriers to data access in HARMONY
Dr Edoardo la Sala - Fondazione GIMEMA, Italy, HARMONY Associated Member
Overcoming barriers to data access in HARMONY ( Dr Edoardo la Sala - Fondazione GIMEMA, Italy, HARMONY Associated Member )
26 Nov 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation